Cresendo Pharmaceuticals Private Limited
About Cresendo Pharmaceuticals Private Limited
Data last updated:
Cresendo Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51101TG2016PTC102651. Its GSTIN is 36AAGCC3199P1ZY (Telangana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Pradeep Pendyala and Venkat Reddy Balanagari.
Its last annual general meeting (AGM) was held on 29 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹3.77 Lakh, a growth of 146% compared to the previous year. For the same year it recorded a net profit of ₹20,231 (net margin 5.4%) and EBITDA of ₹26,974 (EBITDA margin 7.1%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Cresendo Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No M73 To M79 1st Floor Surya Prakash Complex Opp.Swapnatheatre Backside Tsiic Office, Kattendhan, Hyderabad, Telangana, India – 500077
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Cresendo Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cresendo Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Cresendo Pharmaceuticals Private Limited, buy the company report.
Financials of Cresendo Pharmaceuticals Private Limited
FY 2023 filings availableCresendo Pharmaceuticals Private Limited reported revenue of ₹3.77 Lakh (up 146% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 146% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 13%. EBITDA rose 317% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹3.77 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26,974 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20,231 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.1% | ||||
| Net Profit Margin | 5.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cresendo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cresendo Pharmaceuticals Private Limited
Cresendo Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pradeep Pendyala | Director | 08 Jan 2016 | 10 Years 9 Months | Current |
| Venkat Reddy Balanagari | Director | 08 Jan 2016 | 10 Years 9 Months | Current |
Auditor
Cresendo Pharmaceuticals Private Limited is audited by CHEPURI SRINIVASA RAO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHEPURI SRINIVASA RAO | FY 2023 | 234648 |
Shareholding
The shareholding of Cresendo Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cresendo Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cresendo Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cresendo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cresendo Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCC3199P1ZY | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cresendo Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cresendo Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Pradeep Pendyala was appointed as Director on 08 Jan 2016.
Frequently asked questions
Cresendo Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 January 2016 (10+ years old) and is registered under CIN U51101TG2016PTC102651.
Cresendo Pharmaceuticals has 2 current directors:
- Pradeep Pendyala - Director
- Venkat Reddy Balanagari - Director
The latest financial statements of Cresendo Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 29 September 2023. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Cresendo Pharmaceuticals is 36AAGCC3199P1ZY, registered in Telangana.
The CIN (Corporate Identification Number) of Cresendo Pharmaceuticals is U51101TG2016PTC102651. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cresendo Pharmaceuticals was incorporated on 08 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
Pradeep Pendyala was appointed as Director on 08 Jan 2016. Venkat Reddy Balanagari was appointed as Director on 08 Jan 2016.
The registered office of Cresendo Pharmaceuticals is at Plot No M73 To M79 1st Floor Surya Prakash Complex Opp.Swapnatheatre Backside Tsiic Office, Kattendhan, Hyderabad, Telangana, India – 500077.
Cresendo Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Cresendo Pharmaceuticals is compliant as of 30 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
